Insulin medicines
Medicines that replace the insulin a diabetic body lacks.
Health products · No. 68
- Electrical and chemical age
WHO said in 2021 that three multinational companies control more than 90% of the insulin market.
Chart: Illustration: Insulin medicines
Where it comes from
Chart: Map of where it comes from
Eli Lilly began selling the first commercial insulin product, Iletin, in 1923. In 1982 the FDA approved Humulin, a human insulin made by bacteria and the first FDA-approved recombinant drug of any kind, and Humalog, a rapid analogue, followed in 1996.
Three things to know
- WHO says one out of every two people with type 2 diabetes who need insulin does not get it.
- In 2022 US manufacturer gross prices per 100 units of insulin were on average 9.71 times those in 33 OECD comparison countries combined, and 2.33 times after estimated discounts.
- A once-weekly basal insulin cut pens per patient from 22 to 5 a year in a French model by authors from Novo Nordisk and the consultancy Putnam.
The journey
- 1 ProductionYeast or bacteria carrying the human insulin gene make a precursor of the hormone
- 2 ConversionAn enzyme turns the precursor into human insulin, with a refolding stage in the E. coli route; some analogues are then chemically modified
- 3 FillingThe medicine is formulated and filled into vials, cartridges or pre-filled pens
- 4 UseInjected under the skin: 22 pens a year for once-daily basal insulin against 5 for once-weekly, in a French model by Novo Nordisk and Putnam authors
- 5 End of lifeIn the UK, Novo Nordisk takes back used pens and sends them to Denmark, where the plastic is recycled